Company news
Sansure Biotech Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
(688289)"Sansure Biotech Inc."Report for Q3 2026
October 28, 2026
(688289)"Sansure Biotech Inc."Announcement on Convening the Q3 2026 Performance Briefing
October 28, 2026
(688289)"Sansure Biotech Inc."Announcement on Issuance Results of the 1st Tranche of Medium-term Notes for 2026
October 26, 2026
(688289)"Sansure Biotech Inc."Announcement on Satisfaction of Vesting Conditions for the Fourth Vesting Period of Initial Grant and the Third Vesting Period of Reserved Grant under the 2021 Restricted Share Incentive Plan
October 21, 2026
(688289)"Sansure Biotech Inc."Announcement on Resolutions of the 9th Extraordinary Meeting of the 3rd Board of Directors in 2026
October 21, 2026
(688289)"Sansure Biotech Inc."Announcement on Cancellation of Certain Granted but Unvested Restricted Shares under the 2021 Restricted Share Incentive Plan
October 21, 2026
(688289)"Sansure Biotech Inc."Announcement on Adjustment of the Grant Price under the 2021 Restricted Share Incentive Plan
October 21, 2026
(688289)"Sansure Biotech Inc."Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificates for Relevant Products
October 12, 2026
(688289)"Sansure Biotech Inc."Announcement on Implementation of Dividend Distribution for the First Half of 2026
October 8, 2026
Announcement on Approval of Registration for Medium-term Notes
September 28, 2026
Announcement on Results of Completion of Execution of Certain Shares Held by the Former Shareholder Holding More Than 5% of the Shares
September 18, 2026
Announcement on Resignation of the Board Secretary and Designation of the Chairman to Act as the Board Secretary
September 15, 2026
Announcement on Resolutions of the 4th Extraordinary General Meeting in 2026
September 11, 2026
Special Report on the Deposit, Management and Actual Use of Raised Funds for the First Half of 2026
August 26, 2026
Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificates for Relevant Products
August 18, 2026
Announcement on Use of Certain Temporarily Idle Raised Funds for Cash Management
August 14, 2026
Indicative Announcement on the Proposed Judicial Enforcement of Certain Shares Held by a Former Shareholder Holding More Than 5% of the Shares
August 10, 2026
Announcement on Voluntary Disclosure of Obtaining EU CE Certification for Relevant Products
August 3, 2026
Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificate for Relevant Products
July 29, 2026
Announcement on Implementation Results of Share Repurchase
July 17, 2026
Announcement on Voluntary Disclosure of the Obtaining of Medical Device Registration Certificates for Relevant Products
July 15, 2026
Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2026
July 9, 2026
Announcement on Progress in Repurchasing Shares through Call Auction
June 30, 2026
Announcement on Initially Repurchasing Shares through Call Auction
June 25, 2026
Announcement on the Implementation Results of the Judicial Compulsory Execution of Partial Shares of a Shareholder Holding Over 5% Shares
June 24, 2026
Announcement on Changing the Purpose of and Canceling Partial Repurchased Shares and Reducing Registered Capital
June 23, 2026
Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 5% Scale
June 22, 2026
Indicative Announcement on the Implementation Results of the Judicial Compulsory Execution of Partial Shares of a Shareholder Holding Over 5% Shares and the Proposed Further Judicial Compulsory Execution
June 18, 2026
Announcement on Implementation of Dividend Distribution for 2025
June 12, 2026
Announcement on Reply to the Supervision and Inquiry Letter Regarding Information Disclosure of the 2025 Annual Report
June 11, 2026
Announcement on Joint Capital Increase in Hunan Sansure SpeedBio Biotechnology Co., Ltd. with a Related Party
June 4, 2026
Announcement on Vesting Results in the 2nd Vesting Period of 2023 Restricted Stock Incentive Plan
June 1, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 20, 2026
Report for Q1 2026
April 29, 2026
Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificate by Relevant Products
April 28, 2026
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
April 23, 2026
Notice on Convening the 2nd Extraordinary General Meeting in 2026
April 7, 2026
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
March 31, 2026
Announcement on Joint Investment with a Related Party in Huasi Wuwei Technology (Shenzhen) Co., Ltd.
March 15, 2026
Announcement on Joint Investment with a Related Party in Beijing Zheyuan Technology Co., Ltd.
March 12, 2026
Announcement on Preliminary Earnings Estimate for 2025
February 27, 2026
Announcement on Voluntary Disclosure of Clinical Trial Approval for New Indications of a Product of a Holding Subsidiary
February 26, 2026
Announcement on Progress in Establishing a Fund through Co-investment with Professional Institutions and Related Party Transaction
February 11, 2026
Announcement on Vesting Results for the 1st Vesting Period of the Initial Granted Part under the 2023 Phase II Restricted Stock Incentive Plan
December 19, 2025
Announcement on Voluntary Disclosure in the Related Product Obtaining the EU CE Certification
December 11, 2025
Indicative Announcement on Proposed Judicial Freezing and Enforcement of Some Shares Held by Shareholder with Over 5% Shares
December 5, 2025
Announcement on Resolutions of the 5th Extraordinary Meeting of the 3rd Board of Directors in 2025
November 28, 2025
Announcement on Convening the Q3 2025 Performance Briefing
November 25, 2025
Announcement on Resolutions of the 4th Extraordinary General Meeting in 2025
November 17, 2025
Announcement on Voluntary Disclosure in the Related Product Obtaining the Medical Device Registration Certificate and the EU CE Certification
November 7, 2025